Large clear cell sarcoma of the kidney mistaken as Wilms' tumor  by Short, Scott S. et al.
Contents lists available at ScienceDirect
J Ped Surg Case Reports 1 (2013) 235e238Journal of Pediatric Surgery CASE REPORTS
journal homepage: www.jpscasereports .comLarge clear cell sarcoma of the kidney mistaken as Wilms’ tumorScott S. Short c,*, Osnat Zmora c, Catherine J. Hunter c, Larry Wang b, Stuart Siegel a, Henri R. Ford caDepartment of Hematology/Oncology, Children’s Hospital Los Angeles, 4650 Sunset Blvd., MS #100, Los Angeles, CA 90027, USA
bDepartment of Pathology, Children’s Hospital Los Angeles, 4650 Sunset Blvd., Los Angeles, CA 90027, USA
cDepartment of Surgery, Children’s Hospital Los Angeles, 4650 Sunset Blvd., Los Angeles, CA 90027, USAa r t i c l e i n f o
Article history:
Received 22 May 2013
Received in revised form
5 July 2013
Accepted 9 July 2013
Key words:
Clear cell sarcoma
Wilms’ tumor
Kidney* Corresponding author. Tel.: þ1 323 361 2104; fax:
E-mail addresses: sshort@chla.usc.edu, scott.short@
2213-5766  2013 The Authors. Published by Elsevier
http://dx.doi.org/10.1016/j.epsc.2013.07.006a b s t r a c t
Clear cell sarcoma of the kidney (CCSK) is a rare tumor. It has a wide histologic spectrum and often
mimics other pediatric renal tumors, resulting in considerable diagnostic difﬁculty. We report the case of
a two-year-old who presented with a large (14 cm) abdominal mass. Prior to neoadjuvant chemotherapy,
a biopsy was performed, which revealed Wilms’ tumor. The ﬁnal pathology diagnosis at the time of
resection revealed CCSK.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license. The differential diagnosis for an abdominal mass in a two-year-
old child is broad and includes lesions of hepatic, renal, gastroin-
testinal, adrenal, and lymphatic origins. Of these, Wilms’ tumor and
neuroblastoma are the most common tumors [1], with Wilms’ tu-
mor representing 92% of renal masses in children [2]. Non-Wilms’
renal tumors, rhabdoid tumors, and clear cell sarcoma of the kidney
(CCSK) are uncommon. In fact, CCSK is particularly rare and rep-
resents only 17% of non Wilms’ renal tumors in children with only
60 cases reported to the Surveillance Epidemiology and End Results
(SEER) database between 1973 and 2005 [3]. In this report we
present a child presenting with a huge renal mass consistent with
Wilms’ tumor on computed tomography (CT) and initial biopsy.
However, the ﬁnal pathologic diagnosis after resection revealed a
CCSK.1. Case report
A two-year-old boy presented with a one-year history of an
enlarging abdominal mass. The patient was initially evaluated in
Haiti and sent to the USNS Comfort Ship for further workup. CT at
that time revealed a 14 cm heterogeneous mass arising from theþ1 323 361 8678.
cshs.org (S.S. Short).
Inc. Open access under CC BY license.right kidney, consistent with Wilms’ tumor. He was referred to a
non-governmental organization, Angel Mission, which arranged
transfer to a large pediatric hospital in the United States for deﬁn-
itive care. No other pertinent medical or surgical history was re-
ported at the time of transfer.
The patient presented to our institution with a very large
abdominal mass that was associated with respiratory embarrass-
ment, failure to thrive secondary to early satiety, and difﬁculty
walking. There was no family history of malignancy. Physical exam
revealed a malnourished, cachectic appearing child with a large
palpable abdominal mass occupying the entire right upper, right
lower and left lower quadrants. Marked superﬁcial venous collat-
eral circulation was noted on the anterior lower chest and upper
mid-abdominal wall. He was hypertensive with a blood pressure of
125/86. Pertinent laboratory data included hemoglobin of 6.7 with
a mean corpuscular volume of 58.1 and albumin of 2.6; he also was
iron deﬁcient. He was started on amlodipine, enalapril, and iron
replacement therapy. Nasojejunal feeds were instituted to improve
his nutritional status. CT of the chest, abdomen, and pelvis was
performed and revealed a 17 2017 cm heterogeneous mass
arising from the right kidney, consistent withWilms’ tumor (Fig. 1).
The infrahepatic inferior vena cava (IVC) could not be visualized by
CT or abdominal ultrasound. The intrahepatic vena cava, however,
was patent by abdominal Doppler ultrasound. There was no evi-
dence of metastatic diseases visualized.
Given themassive size of the tumor, the patient’s poornutritional
status, and thepossibility of tumor thrombuswithin the infrahepatic
IVC the patientwas taken to the operating room for open biopsy and 
Fig. 1. Computed tomography of the abdomen demonstrating a large heterogeneous
mass with mass effect, ascites, and possible invasion of the inferior vena cava. A, B,
and C demonstrate displacement of the abdominal viscera in the axial, coronal and
sagittal planes respectively.
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opsies of the tumorwere obtained and sent for pathology. Pathology
revealed primitive tumor cells with hyperchromatic nuclei, small
amount of cytoplasm and indistinctive cell borders consistentwith a
Wilms’ tumor with favorable histology (Fig. 2A). FISH was negative
for rearrangementof 22q12 EWSR1 andRT-PCRdid not demonstrate
translocations in EWS-FT1, EWS-EGR, PAX-FOX01, SYT-SSX, EWS-
WT1, and ETV6-NTKR3. Further staining with vimentin, CD99
(Mic-2), CD56, andBCL-2werepositive.WT-1, cytokeratin, epithelial
membrane antigen (EMA), desmin, S100, CD34, tyrosine hydroxy-
lase, synaptophysin, and chromgranin A were negative.
The child underwent neoadjuvant chemotherapy consisting of
vincristine, dactinomycin and adriamycin (regimen DD4A) for 6
weeks followed by repeat imaging. The CT revealed virtually no
response to chemotherapy, and no new areas of progressive or
metastatic disease. After multidisciplinary discussion it was felt
that surgical resection was the best option for this child.
Exploratory laparotomy revealed a gigantic right-sided tumor
with associated lymphadenopathy. Bilateralmedial visceral rotationwas performed to clearly identify tumor boundaries and deﬁne
the vascular anatomy. The infrahepatic IVC was stretched over the
tumor but patent. Great care was taken to preserve the left
renal vein as well as the signiﬁcantly enlarged left gonadal vein. A
right radical nephrectomy was completed. The tumor measured
25.8 19.214.3 cm and weighed 3.1 kg (Fig. 3). Multiple enlarged
aorto-caval lymph nodes were resected and the ascending and
descending colon were ﬁxed to the abdominal wall. The child
tolerated the procedure well and recovered uneventfully from his
procedure without any complication.
The ﬁnal pathologic diagnosis revealed CCSK as supported by
the original immunohistochemical panel. A ﬁne vascular pattern
was appreciated on the gross specimen and review by a member of
the Children’s Oncology Group Renal Pathology Center conﬁrmed
the diagnosis (Fig. 2B). Focal penetration of the capsule and nine
negative lymph nodes were identiﬁed. The patient was observed in
the pediatric intensive care unit overnight, and transferred to the
ward the following day. By postoperative day number 3 he was
tolerating a regular diet. His superﬁcial collateral venous pattern
resolved within the ﬁrst 24 h after surgery. Following diagnosis of
clear cell sarcoma, a metastatic workup, including a bone scan and
magnetic resonance imaging (MRI) of the brain, was performed and
was negative formetastatic disease. He underwent and completed a
course of radiation therapy to the abdomen as well as a course of
adjuvant chemotherapy (regimen I), which consisted of alternating
courses of vincristine, doxorubicin, and cyclophosphamide fol-
lowed by the combination of cyclophosphamide and etoposide.
No evidence of recurrent tumor has been noted 15 months from
surgery.
2. Discussion
CCSK is a tumor that is frequently misdiagnosed due to its rarity
and lack of speciﬁc features. Most patients present between two
and three years of age [4] and show a 2:1 male to female pre-
dominance [5]. Clinical features are nonspeciﬁc making diagnosis of
CCSK difﬁcult. Workup should follow standard algorithms for an
abdominal mass. CT and ultrasonography do not provide discrimi-
natory ﬁndings that would differentiate between CCSK and Wilms’
tumor [6]. Suspicion of CCSK should be heightened in childrenwith
evidence of bony metastases, which may develop in up to 60% of
patients with CCSK compared to a 2% incidence of bony metastases
in Wilms’ tumor [4]. CCSK may also have a higher predilection to
metastasize to liver, brain, and lung [7].
While not routine in the United States, preoperative percuta-
neous biopsy of suspected Wilms’ tumors has been described
and adopted by the United Kingdom Children’s Cancer Study
Group (UKCCSG). They recommend this approach for pathologic
diagnosis prior to chemotherapy because they have found a high
concordance between percutaneous biopsy and ﬁnal surgical pa-
thology in 94%e99% of cases [8]. Furthermore, use of pretreatment
biopsy has not been associated with any increase in recurrence or
complication [9].
Unfortunately, this patient fell into the small cohort of patients
whose diagnosis on initial biopsy is discordant with the ﬁnal path-
ologic diagnosis. CCSK is a malignant mesenchymal neoplasm
characterized by undifferentiated cells with abundant extracellular
matrix that are separated into cords and nests by a ﬁne vascular
network. Although the majority of CCSK have “classic” features on
pathologic examination it is well known that CCSK is difﬁcult to
differentiate from other “renal blue round cell lesions” such as
blastemalWilms’ tumor and primitive neuroectodermal tumor. The
primary contribution of immunohistochemical analysis in the
diagnosis of CCSK is the exclusionof other pediatric renalneoplasms,
whereas immunohistochemical study has a limited role in the
Fig. 2. A. Wilms’ e H&E slide shows a cellular tumor composed of primitive tumor cells with hyperchromatic nuclei, small amount of cytoplasm and indistinctive cell borders.
Mitotic ﬁgures are noted. B. Clear cell sarcoma of the kidney (CCSK) e H&E slide shows tumor cells are separated by pale-pink vascular-rich stroma and contain nuclei with ﬁnely
dispersed chromatin.
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stromal cells of Wilms’ tumor, CCSK regularly expresses vimentin,
but other differentiation markers including epithelial markers
(cytokeratin, EMA), desmin, S100 protein and neuron speciﬁc
enolase are usually absent. Furthermore, immunohistochemical re-
action for WT1 protein in Wilms’ tumor is variable and correlation
with tumor histology is still required. Further, while WT1 immu-
noreactivity may be useful in distinguishing between blastemal
Wilms’ tumor (highWT1 expression) and other primitive tumors, it
is not useful in tumors with only stromal differentiation, as seen in
this CCSKcase.Other factors knowntobeuniformlynegative inCCSK
include CD99 (Mic-2) and CD56, which are positive in this case [10].
Others have reported that the muscle speciﬁc actin may sometimes
show positivity and vimentin staining may be much stronger in
CCSK, which may be helpful in distinguishing CCSK from Wilms’
tumor [11]. However, no single immunohistochemical reaction is
universally diagnostic forWilms’ tumor as well as CCSK. Other clues
to the diagnosis of CCSK includewell separated nuclear spacing, ﬁne
chromatin, and younger mean age of patient [5].
While these differences may help distinguish CCSK from other
pathology it remains the most commonly misdiagnosed pediatric
renal tumor with authors reporting confusion with Wilms’ and
mesoblastic nephroma [5,12,13]. This has prompted investigation
into methods to better discern CCSK from other entities. Ueno and
colleagues recently sought to characterize the molecular signatureFig. 3. Intra-operative image of a large renal mass with distorted anatomy and
displacement of the IVC.of different pediatric renal neoplasms. They evaluated specimens
from 83 pediatric patients including 21 with CCSK and 41 with
Wilms’. They found that CCSK is generally hypermethylated
particular at the site THBS1 CPG, a suspected angiogenic factor.
All children with CCSK were found to be hypermethylated at
this loci and all children with an alternative renal neoplasm were
not hypermethylated [14]. Others have evaluated and reported
different genetic mutations associated with CCSK including
rearrangement of YWAE on chromosome 17, translocation of
t(10;17)(q22;p13), EFGR ampliﬁcation, and deletions in chromo-
some 14q [7,15]. However, these genetic mutations appear sporadic
with no familial cases of CCSK reported to date [7]. Currently there
are no deﬁned algorithms and most authors recommend referral of
samples to pathologists with experience evaluating pediatric renal
neoplasms, which were helpful for successful diagnosis in this case.
Once diagnosis of CCK is conﬁrmed treatment is radical ne-
phrectomy followed by adjuvant chemoradiation. The National
Wilms’ Tumor Study Group (NWTSG) guidelines call for cyclo-
phosphamide, etoposide, vincristine, and doxorubicin for any stage
of CCSK [16]. Doxorubicin has been reported to impart signiﬁcant
improvements in survival [5] and prolonged chemotherapy regi-
mens may improve relapse free survival [17]. Although some have
withheld adjuvant radiotherapy in childrenwith stage I disease, the
addition of radiotherapy (10 Gy) to the tumor bed is standard in
protocols for patients of any stage with CCSK [18].
Despite having unfavorable histology associated long term sur-
vival is reasonable with nearly 79% of patients alive at 10 years [3].
TNM staging classiﬁcation for CCSK is the same as Wilms’ and
prognosis varies by respective stage. Overall survival of 100% for
stage I, 97% for stage II, 87% for stage III, and 45% for stage IV disease
have been reported [19].
3. Conclusion
In summary, CCSK is an uncommon tumor of renal origin that is
challenging to diagnose and should be considered in the differential
diagnosis of a pediatric patient presenting with a palpable abdom-
inal mass. Further research is needed to develop better methods of
diagnosis and tissue should undergo evaluation by pathologists
familiar with subtleties between pediatric renal neoplasms.
Consent
Written informed consent was obtained from the patient for
publication of this case report and accompanying images. A copy of
the written consent is available for review by the Editor-in-Chief of
this journal on request.
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